Electrocardiography Screening for Atrial Fibrillation: We Can Do Better

Rod Passman; Jonathan Piccini

doi:10.1001/jamacardio.2018.2200

Electrocardiography Screening for Atrial Fibrillation: We Can Do Better

Rod Passman^*, Jonathan Piccini

^*Corresponding author for this work

Medicine, Cardiology Division

Research output: Contribution to journal › Editorial › peer-review

6 Scopus citations

Original language	English (US)
Pages (from-to)	1144-1145
Number of pages	2
Journal	JAMA cardiology
Volume	3
Issue number	12
DOIs	https://doi.org/10.1001/jamacardio.2018.2200
State	Published - Dec 2018

ASJC Scopus subject areas

Cardiology and Cardiovascular Medicine

Access to Document

10.1001/jamacardio.2018.2200

Cite this

@article{da5c13facbe64b39ab449b0c8b837b0c,

title = "Electrocardiography Screening for Atrial Fibrillation: We Can Do Better",

author = "Rod Passman and Jonathan Piccini",

note = "Funding Information: have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Passman reports grants from Kardia and grants and personal fees from Medtronic outside the submitted work. Dr Piccini reports consulting fees from Allergan, Bayer, Johnson & Johnson, Medtronic, Sanofi, and Philips and grants to his institution from ARCA Biopharma, Boston Scientific, Gilead Sciences, Janssen Pharmaceuticals, Abbott Laboratories, and Verily Life Sciences during the conduct of the study. No other disclosures were reported.",

year = "2018",

month = dec,

doi = "10.1001/jamacardio.2018.2200",

language = "English (US)",

volume = "3",

pages = "1144--1145",

journal = "JAMA Cardiology",

issn = "2380-6583",

publisher = "American Medical Association",

number = "12",

}

TY - JOUR

T1 - Electrocardiography Screening for Atrial Fibrillation

T2 - We Can Do Better

AU - Passman, Rod

AU - Piccini, Jonathan

N1 - Funding Information: have completed and submitted the ICMJE Form for Disclosure of Potential Conflicts of Interest. Dr Passman reports grants from Kardia and grants and personal fees from Medtronic outside the submitted work. Dr Piccini reports consulting fees from Allergan, Bayer, Johnson & Johnson, Medtronic, Sanofi, and Philips and grants to his institution from ARCA Biopharma, Boston Scientific, Gilead Sciences, Janssen Pharmaceuticals, Abbott Laboratories, and Verily Life Sciences during the conduct of the study. No other disclosures were reported.

PY - 2018/12

Y1 - 2018/12

UR - http://www.scopus.com/inward/record.url?scp=85052723619&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85052723619&partnerID=8YFLogxK

U2 - 10.1001/jamacardio.2018.2200

DO - 10.1001/jamacardio.2018.2200

M3 - Editorial

C2 - 30087985

AN - SCOPUS:85052723619

SN - 2380-6583

VL - 3

SP - 1144

EP - 1145

JO - JAMA Cardiology

JF - JAMA Cardiology

IS - 12

ER -

Electrocardiography Screening for Atrial Fibrillation: We Can Do Better

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this